Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $14.23 USD
Change Today -0.18 / -1.25%
Volume 2.2K
PMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 1:23 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

psychemedics corp (PMD) Snapshot

Open
$14.30
Previous Close
$14.41
Day High
$14.42
Day Low
$14.17
52 Week High
04/27/15 - $17.83
52 Week Low
09/16/14 - $12.42
Market Cap
76.5M
Average Volume 10 Days
11.0K
EPS TTM
$0.55
Shares Outstanding
5.4M
EX-Date
05/6/15
P/E TM
26.1x
Dividend
$0.60
Dividend Yield
4.20%
Current Stock Chart for PSYCHEMEDICS CORP (PMD)

Related News

No related news articles were found.

psychemedics corp (PMD) Related Businessweek News

No Related Businessweek News Found

psychemedics corp (PMD) Details

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s testing methods utilize a patented technology that focuses on digesting hair and releasing drugs trapped in the hair without destroying the drugs. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.

156 Employees
Last Reported Date: 02/27/15
Founded in 1985

psychemedics corp (PMD) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $536.9K
Vice President of Laboratory Operations
Total Annual Compensation: $310.3K
Corporate Vice President of Sales & Marketing
Total Annual Compensation: $241.8K
Compensation as of Fiscal Year 2014.

psychemedics corp (PMD) Key Developments

Psychemedics Corp. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Psychemedics Corp. reported unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net income of $277,522, or $0.05 per basic and diluted share; down from $756,159, or $0.14 per basic and diluted share in the last year. Revenues were $6,755,741 compared to $7,044,821 a year ago. Operating income was $450,515 compared to $1,168,052 a year ago. Net income before provision for income taxes was $417,188 compared to $1,169,601 a year ago.

Psychemedics Corporation Announces Quarterly Dividend, Payable on May 18, 2015

Psychemedics Corporation announced a quarterly dividend of $0.15 per share payable to shareholders of record as of May 8, 2015 to be paid on May 18, 2015. This will be the company's 75th consecutive quarterly dividend.

Psychemedics Corp., Annual General Meeting, Apr 29, 2015

Psychemedics Corp., Annual General Meeting, Apr 29, 2015., at 14:00 US Eastern Standard Time. Location: at the Seaport Hotel, 200 Seaport Boulevard. Agenda: To elect directors of the Company for the ensuing year and until their respective successors are chosen and qualified; to conduct a non-binding advisory vote on the compensation of named executive officers; to ratify the audit committee’s appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015; and to consider and act upon matters incidental to the foregoing and to transact such other business as may properly come before the annual meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMD:US $14.23 USD -0.18

PMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $19.25 USD -0.2301
Enzo Biochem Inc $2.46 USD -0.025
Genomic Health Inc $27.30 USD -0.09
NeoGenomics Inc $5.40 USD -0.02
Response Genetics Inc $0.40 USD +0.0269
View Industry Companies
 

Industry Analysis

PMD

Industry Average

Valuation PMD Industry Range
Price/Earnings 28.3x
Price/Sales 2.7x
Price/Book 6.2x
Price/Cash Flow 28.2x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSYCHEMEDICS CORP, please visit www.psychemedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.